As. Tischler et al., SUSTAINED STIMULATION OF RAT ADRENAL CHROMAFFIN CELL-PROLIFERATION BYRESERPINE, Toxicology and applied pharmacology, 135(2), 1995, pp. 254-257
Chronic administration of reserpine is associated with the development
of pheochromocytomas in rats. Short-term administration of reserpine
to rats has been shown to stimulate chromaffin cell proliferation, lea
ding to the hypothesis that reserpine causes pheochromocytomas indirec
tly by providing a proliferative backdrop on which genetic damage may
occur. However, it is not known whether the proliferative effects of r
eserpine persist long enough for this model to be tenable. In the pres
ent investigation, the effects of reserpine on bromodeoxyuridine (BrdU
) incorporation into epinephrine (E)- and norepinephrine (NE)-type chr
omaffin cells were studied after 1, 4, and 12 weeks of reserpine admin
istration. Reserpine administered in the diet at 10 or 50 ppm was show
n to result in a persistent mitogenic stimulation of the rat adrenal m
edulla. Cells that incorporated BrdU at all time points appeared to be
typical E- and NE-type chromaffin cells, and the ratio of BrdU-labele
d E cells to BrdU-labeled NE cells was not altered by reserpine. An ad
ditional observation was that the ratio of all E cells to all NE cells
declined after Week 1 and that the decline could be accelerated by ad
ministration of reserpine. This finding suggests that neural stimulati
on of chromaffin cells might play a role in age-related functional cha
nges of the adrenal medulla during early adult life. The present obser
vations support the hypothesis that reserpine induces pheochromocytoma
s indirectly by increasing chromaffin cell proliferation. They also de
crease the likelihood that rat pheochromocytomas arise from preferenti
al stimulation of proliferation of a particular cell type. (C) 1995 Ac
ademic Press, Inc.